Drugs / teriflunomode
last change Aug 2022 re-read 2 minutes ago

teriflunomode

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04792567 Comparator Apr → Sep 2021 secondary progressive multiple sclerosis Novartis Pharmaceuticals Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as teriflunomode “DMTs: Dimethylfumarate, glatirameracetate, interferon, teriflunomode according to respective SmPC” NCT04792567